HTA172 Value of French Framework for Early Access Programs for the HTA Appraisal in the Rare Disease Spa The Example of Lanadelumab in Patients With Hereditary Angioedema
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1856
https://www.valueinhealthjournal.com/article/S1098-3015(23)04986-0/fulltext
Title :
HTA172 Value of French Framework for Early Access Programs for the HTA Appraisal in the Rare Disease Spa The Example of Lanadelumab in Patients With Hereditary Angioedema
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04986-0&doi=10.1016/j.jval.2023.09.1856
First page :
Section Title :
Open access? :
No
Section Order :
11299